Oscar Health, Inc. (NYSE:OSCR) Vice Chairman Joshua Kushner Acquires 276,040 Shares

Oscar Health, Inc. (NYSE:OSCRGet Free Report) Vice Chairman Joshua Kushner purchased 276,040 shares of the stock in a transaction dated Monday, November 11th. The shares were purchased at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the transaction, the insider now directly owns 5,031,262 shares of the company’s stock, valued at approximately $68,324,537.96. The trade was a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Joshua Kushner also recently made the following trade(s):

  • On Wednesday, November 13th, Joshua Kushner bought 358,619 shares of Oscar Health stock. The stock was acquired at an average price of $13.74 per share, for a total transaction of $4,927,425.06.

Oscar Health Price Performance

NYSE OSCR opened at $13.48 on Thursday. The firm has a market capitalization of $3.26 billion, a price-to-earnings ratio of -224.63, a price-to-earnings-growth ratio of 12.49 and a beta of 1.67. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.91. The company has a 50 day simple moving average of $18.28 and a 200-day simple moving average of $18.30. Oscar Health, Inc. has a 52-week low of $6.93 and a 52-week high of $23.79.

Oscar Health (NYSE:OSCRGet Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The firm had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same period in the prior year, the company posted ($0.29) earnings per share. Oscar Health’s quarterly revenue was up 68.3% on a year-over-year basis. Equities research analysts predict that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Oscar Health

Several institutional investors and hedge funds have recently made changes to their positions in the company. FORA Capital LLC acquired a new stake in Oscar Health during the 3rd quarter valued at $237,000. FMR LLC increased its stake in shares of Oscar Health by 29.5% in the third quarter. FMR LLC now owns 109,002 shares of the company’s stock valued at $2,312,000 after buying an additional 24,801 shares in the last quarter. Quantbot Technologies LP acquired a new position in Oscar Health during the 3rd quarter worth about $1,297,000. The Manufacturers Life Insurance Company grew its holdings in Oscar Health by 7.3% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 353,072 shares of the company’s stock worth $7,489,000 after acquiring an additional 23,943 shares during the last quarter. Finally, Westfield Capital Management Co. LP acquired a new stake in Oscar Health in the 3rd quarter valued at about $27,452,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently weighed in on OSCR. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and reduced their price target for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Piper Sandler reiterated an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. Finally, UBS Group began coverage on Oscar Health in a report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective for the company. One investment analyst has rated the stock with a sell rating, two have given a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Oscar Health currently has a consensus rating of “Moderate Buy” and an average price target of $22.93.

Read Our Latest Stock Analysis on OSCR

About Oscar Health

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Recommended Stories

Insider Buying and Selling by Quarter for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.